Menorrhagia Study in Women With Treatment-resistant Menorrhagia

• Status: Completed
• Trial end date: 2004-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to explore effects of the investigational product for the treatment of treatment-resistant menorrhagia without organic cause.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Collaborator: TAP Pharmaceutical Products Inc.

Criteria

Inclusion Criteria:

• Patients with treatment-resistant menorrhagia scheduled for hysterectomy.

Exclusion Criteria:

• Organic causes of menorrhagia

• Current hormone treatment